Clinical Trial Update: Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF [Phase 3]

View source ↗

Summary

This entry reports the results of a Phase 3 trial evaluating aztreonam for inhalation solution (AZLI) given in a continuous alternating therapy regimen to treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Aztreonam for Inhalation Solution (AZLI) (aztreonam for inhalation)

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2016-05-09